Showing 1 to 8 of 8 results
Shingles Vaccine Linked to Reduced Risk of Heart Attack and Stroke
A new study funded by GSK, the manufacturer of a shingles vaccine, found that adults who received the shingles vaccine had an 18% lower risk of major cardiac events, with a 16% reduction among those over 50; however, the study's observational nature prevents establishing direct causality.
Shingles Vaccine Linked to Reduced Risk of Heart Attack and Stroke
A new study funded by GSK, the manufacturer of a shingles vaccine, found that adults who received the shingles vaccine had an 18% lower risk of major cardiac events, with a 16% reduction among those over 50; however, the study's observational nature prevents establishing direct causality.
Progress
24% Bias Score
GSK Stock Rises on $500 Million China Drug Deal
GSK's stock rose 1.58 percent to £14.15 after announcing a $500 million collaboration with China's Hengrui Pharma to develop up to 12 new medicines, including a respiratory drug; this boosted St James's Place and contrasts with falls in telecom, defence and mining stocks, while a US-EU trade deal we...
GSK Stock Rises on $500 Million China Drug Deal
GSK's stock rose 1.58 percent to £14.15 after announcing a $500 million collaboration with China's Hengrui Pharma to develop up to 12 new medicines, including a respiratory drug; this boosted St James's Place and contrasts with falls in telecom, defence and mining stocks, while a US-EU trade deal we...
Progress
36% Bias Score
Trump's Tariff Threat Wipes £14 Billion Off UK Drugmakers
President Trump's threat of US tariffs on pharmaceutical imports caused a £14 billion loss in market value for AstraZeneca and GSK, highlighting the reliance of British drugmakers on US sales and sparking concerns about global supply chain disruptions and potential public health risks due to planned...
Trump's Tariff Threat Wipes £14 Billion Off UK Drugmakers
President Trump's threat of US tariffs on pharmaceutical imports caused a £14 billion loss in market value for AstraZeneca and GSK, highlighting the reliance of British drugmakers on US sales and sparking concerns about global supply chain disruptions and potential public health risks due to planned...
Progress
40% Bias Score
UK Economic Outlook Worsens Amid Fiscal Constraints and Inflation
The UK faces a deteriorating economic outlook, with £10 billion in fiscal space lost to low growth, high inflation, and interest rates, leading to potential emergency budget discussions and impacting the Bank of England's policy decisions.
UK Economic Outlook Worsens Amid Fiscal Constraints and Inflation
The UK faces a deteriorating economic outlook, with £10 billion in fiscal space lost to low growth, high inflation, and interest rates, leading to potential emergency budget discussions and impacting the Bank of England's policy decisions.
Progress
44% Bias Score
Shingles Vaccine May Reduce Heart Attack and Stroke Risk, Study Suggests
A new analysis of 19 studies revealed that adults who received the herpes zoster vaccine, commonly known as the shingles vaccine, had an 18% lower risk of serious cardiovascular events; among those 50 and older, the risk reduction was 16%.
Shingles Vaccine May Reduce Heart Attack and Stroke Risk, Study Suggests
A new analysis of 19 studies revealed that adults who received the herpes zoster vaccine, commonly known as the shingles vaccine, had an 18% lower risk of serious cardiovascular events; among those 50 and older, the risk reduction was 16%.
Progress
28% Bias Score
House Judiciary Committee Investigates Alleged Pfizer Vaccine Delay
The House Judiciary Committee is investigating allegations that Pfizer delayed its Covid-19 vaccine announcement until after the 2020 election, based on a former Pfizer executive's statements to GSK, which Pfizer denies, asserting that the process was driven by science and FDA guidelines.
House Judiciary Committee Investigates Alleged Pfizer Vaccine Delay
The House Judiciary Committee is investigating allegations that Pfizer delayed its Covid-19 vaccine announcement until after the 2020 election, based on a former Pfizer executive's statements to GSK, which Pfizer denies, asserting that the process was driven by science and FDA guidelines.
Progress
52% Bias Score
GSK CEO urges UK government to boost support for pharma industry
GSK's CEO Emma Walmsley says the UK government must increase support for its pharmaceutical industry to prevent it being overtaken by foreign rivals, following AstraZeneca's cancellation of a £450 million vaccine factory near Liverpool due to insufficient state support.
GSK CEO urges UK government to boost support for pharma industry
GSK's CEO Emma Walmsley says the UK government must increase support for its pharmaceutical industry to prevent it being overtaken by foreign rivals, following AstraZeneca's cancellation of a £450 million vaccine factory near Liverpool due to insufficient state support.
Progress
44% Bias Score
GSK and Oxford to Research Cancer-Preventing Vaccines
GSK is investing £50 million in a three-year research program with Oxford University to develop cancer vaccines targeting pre-cancerous cells, leveraging advancements in neoantigen identification and mRNA technology.
GSK and Oxford to Research Cancer-Preventing Vaccines
GSK is investing £50 million in a three-year research program with Oxford University to develop cancer vaccines targeting pre-cancerous cells, leveraging advancements in neoantigen identification and mRNA technology.
Progress
44% Bias Score
Showing 1 to 8 of 8 results